Výsledky vyhledávání - "M, Meriggioli"

S11 Long-term follow-up of the phase 1 START trial of onasemnogene abeparvovec gene therapy in spinal muscular atrophy type 1

Autor: N. Miller, M Meriggioli, Lindsay N. Alfano, Samiah Al-Zaidy, I Kausar, Richard Shell, Kelly J. Lehman, Kathleen Church, A Kleyn, Linda Lowes, Markus McColly, M. Iammarino, J. Mendell, SP Reyna

Publikováno v: Predicting longer term outcomes in children.

Introduction and Objective Onasemnogene abeparvovec (formerly AVXS-101) is designed to address the genetic root cause of spinal muscular atrophy type 1 (SMA1). In the phase 1 trial (START; NCT02122952), patients who received a one-time (proposed ther

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68c9a99d3589ebc016651435a076a8c4
https://doi.org/10.1136/thorax-2020-btsabstracts.17

Zobrazit plný text záznamu

[Can the treatment with L-carnitine improve the inflammation in chronic hemodialysis patients?]

Autor: G, Grazi, M, Meriggioli, G, Donati

Publikováno v: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 21

Inflammation in patients on chronic hemodialysis (HD) is related to malnutrition and atherosclerosis; anemia is also often present in these patients. It has been demonstrated that l-carnitina treatment, in addition to reducing the need for erythropoi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1d25b51a66ab5ab033f91dcca1d25dfb
https://pubmed.ncbi.nlm.nih.gov/15750986

Zobrazit plný text záznamu

Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin

Autor: M, Camici, R, Giordani, E, Morelli, M, Meriggioli, P L, Balestri, G, Barsotti, A, Sagripanti

Publikováno v: Minerva medica. 89(11-12)

The aim of this work is to describe an approach allowing extracorporeal hemodialysis (HD) with administration of low molecular weight heparin (LMWH) and to compare the dialyzer efficiency of this approach versus infractionated heparin (UFH) used alon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c9519892c7e7a76fa43a51c0fe6f04da
https://pubmed.ncbi.nlm.nih.gov/10212664

Zobrazit plný text záznamu

[Coagulation in hemodialysis]

Autor: M, Camici, L, Evangelisti, P, Balestri, L, Cioni, P, Rindi, A, Sagripanti, M, Meriggioli, R, Giordani

Publikováno v: Minerva medica. 87(11)

The authors have evaluated the behaviour of protein C activity, factor X and factor VII coagulant activity, and serum lipoprotein(a) before and after haemodialytic treatment in the plasma of patients on maintenance haemodialysis. The plasma level of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::05f7eb6c7f9d11197edbf994f1b10748
https://pubmed.ncbi.nlm.nih.gov/9045101

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání